Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab.
Risitano, Antonio M
Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. [electronic resource] - Blood Apr 2009 - 4094-100 p. digital
Publication Type: Journal Article
1528-0020
10.1182/blood-2008-11-189944 doi
Antibodies, Monoclonal--immunology
Antibodies, Monoclonal, Humanized
Cell Survival
Complement C3--metabolism
Erythrocytes--metabolism
Female
Flow Cytometry
Hemoglobinuria, Paroxysmal--immunology
Humans
Immunotherapy
Male
Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. [electronic resource] - Blood Apr 2009 - 4094-100 p. digital
Publication Type: Journal Article
1528-0020
10.1182/blood-2008-11-189944 doi
Antibodies, Monoclonal--immunology
Antibodies, Monoclonal, Humanized
Cell Survival
Complement C3--metabolism
Erythrocytes--metabolism
Female
Flow Cytometry
Hemoglobinuria, Paroxysmal--immunology
Humans
Immunotherapy
Male